Hepatic Hemangioma

Introduction

Causes / Etiology

• Congenital origin: Hemangiomas are considered congenital vascular malformations, not acquired tumors. They arise from disordered embryological development of hepatic sinusoids.
• Sex predilection: They occur predominantly in women aged 20 to 50 years, suggesting a hormonal influence.
• Estrogen exposure: Although hemangiomas lack estrogen receptors, estrogen exposure (e.g., oral contraceptive use, pregnancy) is associated with higher rates of enlargement. Importantly, this does not increase the risk of rupture.
• Most are solitary: Approximately 90% of patients present with a single lesion; only ~10% have multifocal disease.

Pathophysiology

Structural Anatomy

• Pseudocapsule: A fibrous cleavage plane exists between the hemangioma and surrounding liver parenchyma - this is clinically important as it facilitates surgical enucleation.
• Thrombosis: Common within the lesion; dystrophic calcification may follow.
• Fibrous interface patterns (Zimmermann's classification, per Maingot's Abdominal Operations):
  1. Fibrous interface - avascular capsule-like fibrous lamellae (most common in large hemangiomas; best for enucleation)
  2. Interdigitating interface - mixture of parenchymal and hemangioma components without a capsule
  3. Compression interface - direct apposition of hemangioma and parenchyma
  4. Irregular/spongy interface - highly irregular border with parenchymal foci interspersed

Blood Supply and Hemodynamics

Natural History

Symptoms and Clinical Presentation

Common Symptoms

• Right upper quadrant or epigastric abdominal pain/discomfort
• Abdominal fullness or pressure sensation
• Early satiety (from compression of adjacent stomach or duodenum)
• Nausea and vomiting

Complications (Rare)

Diagnosis and Imaging

Ultrasound (First-line)

• Well-demarcated, homogeneous, hyperechoic lesion
• Well-circumscribed with posterior acoustic enhancement (no shadowing)
• Particularly accurate for small lesions (<3 cm)
• Contrast-enhanced ultrasound (CEUS) can highlight typical vascular enhancement

CT Scan (Most Common Diagnostic Tool)

1. Low-density lesion on unenhanced scan
2. Early peripheral (nodular) contrast enhancement in arterial phase
3. Progressive centripetal opacification from periphery toward center
4. Delay of at least 3 minutes before total opacification
5. Eventually isodense appearance

MRI (Most Sensitive - 96% Accuracy)

• Hypointense on T1-weighted sequences (vs. surrounding liver)
• Markedly hyperintense on T2-weighted sequences ("light bulb" sign)
• Gadolinium enhancement mirrors the CT pattern (peripheral nodular fill-in)
• Preferred when CT is inconclusive

Management

Four Core Principles (Current Surgical Therapy 14e)

1. The majority of patients, regardless of size, are asymptomatic and do not require intervention.
2. A broad differential diagnosis (GERD, peptic ulcer disease, gallstones) should always be considered before attributing symptoms to a hemangioma.
3. When resection is considered, minimally invasive approaches are preferred when feasible; however, they should not expand indications for treatment.
4. Operative treatment does not improve symptoms in approximately 30-50% of selected patients - careful patient selection is therefore mandatory.

Non-Operative Management (Default for Most Patients)

Indications for Surgery

1. Severe, attributable symptoms refractory to conservative management
2. Inability to confidently exclude malignancy on imaging (diagnostic equipoise)
3. Development of complications (hemorrhage, Kasabach-Merritt syndrome)

Note: Size alone is not an indication for resection. Giant hemangiomas (>10 cm) may be safely observed if asymptomatic.

Surgical Options

• Takes advantage of the fibrous pseudocapsule as a cleavage plane
• Associated with lower postoperative complications vs. formal resection
• Similar transfusion rates to hepatic resection
• In a Memorial Sloan Kettering series, 60% of operative cases were managed by enucleation

• Used when enucleation is not technically feasible (e.g., central or deeply located lesions)
• Minimally invasive (laparoscopic/robotic) approaches preferred when technically feasible

• Used preoperatively to control bleeding in ruptured hemangiomas before surgery
• Can be used pre-resection for giant hemangiomas to reduce intraoperative blood loss
• Used for symptomatic patients who are not surgical candidates
• Controversy exists about long-term symptom relief from embolization alone

• Considered only in exceedingly rare cases of unresectable hemangioma with Kasabach-Merritt syndrome or Budd-Chiari syndrome that cannot otherwise be managed.

Management of Specific Complications

• Kasabach-Merritt syndrome: Surgical resection is the preferred treatment if technically feasible (coagulopathy resolves post-resection). Inoperable cases: embolization with glucocorticoids, propranolol, or cytotoxic therapy. Thromboelastography (TEG) or ROTEM guides perioperative coagulation management.
• Spontaneous rupture: Emergency management with angiographic embolization first to control hemorrhage, followed by surgical resection.
• Budd-Chiari syndrome from hemangioma: Liver resection if hepatic outflow can be preserved; transplantation in extreme cases.

Summary Table